NaureWise Biotech & Medicals Corporation (NBM), a new drug development company founded in the year of 2000, focuses on the botanical drug and small molecule therapies. By taking advantage of our profound knowledge of herbal medicines, we took natural plants as the development target and started from the niche market to systematically develop the new value of natural plants.
Based on the comprehensive evaluation of market, regulatory, and science, we draw up the best development strategies of drug candidates to be used in diseases in need of better treatment modalities. Our products received the Gold Award of Innovation four times in Taipei City’s Biotech Award Contests. Our first product, LipoCol Forte, is the first traditional Chinese medicine approved in Taiwan to lower cholesterol and triglyceride.
We currently specialize in the development of therapeutic drugs for tumors, neurodegenerative diseases, and retinopathy. NBM-BMX is one of our important items in the portfolio, which is a specific HDAC8 inhibitor with superior safety and efficacy for tumor treatment. The phase I clinical trial is ongoing in USA and Taiwan, and expected to be completed on Q3 2020.